Best Thyroid function tests (including T3, T4, TSH) doctors in Turkey: TOP 48 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by

Fahad Mawlood

Mustafa Solak

  • 4.5 Good 160 reviews
  • 19 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
  • Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

  • Read more
Proton-beam therapy
$800 - $1,000
Hysterectomy (uterus removal)
$2,500 - $4,500
Info

Nuri Alper Sahbaz

  • 4.5 Good 160 reviews
  • 20 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
  • Assoc. Prof. Nuri Alper Şahbaz is an experienced doctor with medical education from Istanbul University, Cerrahpaşa Faculty of Medicine, and scientific and clinical experience from Baylor College of Medicine and The University of Texas Medical School. He is specialized in endocrine surgery (thyroid, parathyroid, adrenal gland and neuroendocrine tumors) and has performed over 2000 successful surgeries in this area. He also specializes in laparoscopic and minimally invasive surgeries, as well as in diagnostic and therapeutic gastrointestinal system endoscopy.

  • Read more
Proton-beam therapy
$800 - $1,000
Hysterectomy (uterus removal)
$2,500 - $4,500
Info

Suleyman Hilmi Ipekci

  • 4.5 Good 160 reviews
  • 26 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
  • Assoc. Prof. Süleyman İPEKÇİ, M.D. is a physician specializing in diabetes, thyroid and diabetes diseases, thyroid cancers, pituitary diseases, adrenal gland diseases, and hormone disorders. He graduated from Cerrahpaşa School of Medicine, Istanbul University in 1999, completed his residency in 2005, his fellowship in 2010, and his training for Associate Professorship in 2016. He has authored 42 scientific articles published in international scientific journals and has participated in numerous national and international conferences and projects.
  • Read more
Proton-beam therapy
$800 - $1,000
Hysterectomy (uterus removal)
$2,500 - $4,500
Info

Mustafa Sahin

  • 4.5 Good 3 reviews
  • 37 years of experience
  • Turkey, Istanbul, Büyük Anadolu Hospitals (BAH)
  • Specializations

     

    Cancer Surgery

    Pancreatic Surgery

    Bile Duct Surgery

    Bariatric Metabolic Surgery

    Oncological Surgery

    Breast Surgery

    Gastric cancer

    Colon cancer

    Thyroid Cancer

    Obesity Surgery

    Diabetes Surgeries

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

  • Read more
Surgeon's portfolio

See portfolio

Doctor's visit
Price on request
Info

Suleyman Hilmi Aksoy

  • 4.5 Good 160 reviews
  • 23 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
  • Dr. Hilmi Aksoy was born in 1974 and graduated from Istanbul University's Çapa School of Medicine in 1998. He completed his residency in Radiodiagnostics and Interventional Radiology at Cerrahpaşa School of Medicine in 2002. He has participated in 13 local and international congresses with oral and written presentations. His fields of medical interest include Diagnostic Radiology and Teleradiology and Interventional Radiology. He has worked at Hisar Intercontinental Hospital, Merzifon Air Hospital, Istanbul Emar Center, and Haseki Training and Research Hospital.
  • Read more
Proton-beam therapy
$800 - $1,000
Hysterectomy (uterus removal)
$2,500 - $4,500
Info

Zuhal Tanzer

  • 4.4 Good 80 reviews
  • 36 years of experience
  • Turkey, Istanbul, Lokman Hekim Istanbul Hospital
  • Dr. Zuhal Tanzer is a specialist in Internal Diseases.
Mastectomy
$800 - $1,000
Radiofrequency ablation
$5,000 - $5,000
Metabolic surgery
$5,000 - $5,250
Info

Find out about the best doctors here

20 top ranked Thyroid function tests (including T3, T4, TSH) doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Thyroid function tests (including T3, T4, TSH) doctors on Bookimed.com:

How to choose the best Thyroid function tests (including T3, T4, TSH) doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Thyroid function tests (including T3, T4, TSH) doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Thyroid function tests (including T3, T4, TSH) varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Thyroid function tests (including T3, T4, TSH) if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Zulfu Sertkaya

  • 1 Good 2 reviews
  • 17 years of experience
  • Turkey, Istanbul, Andro Expertise Men's Health and Aesthetics
  • Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.

    Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."

    In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.

  • Read more
Doctor's visit
Price on request
Info

Hilmi Cem Kaya

  • New
  • 4 years of experience
  • Turkey, Istanbul, Medipol University Pendik Hospital
  • 1️⃣ Highly Trained ENT Specialist – Dr. Hilmi Cem Kaya is a skilled expert in Ear, Nose, and Throat (ENT) diseases, trained at top medical institutions in Turkey, ensuring cutting-edge treatments and patient care. 2️⃣ Prestigious Medical Education – Earned his medical degree from Ege University Faculty of Medicine and later specialized in ENT diseases at Uludağ University, a top-tier program known for producing leading ENT specialists. 3️⃣ Experience in Turkey’s Leading Hospitals – Gained valuable expertise working at: 🔹 Sultan Abdulhamid Han Training and Research Hospital (2023) 🔹 Martyr Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital (2021-2022) These institutions are known for their advanced surgical techniques and comprehensive patient care. 4️⃣ Expert in Modern ENT Treatments – Specializing in the latest medical advancements in ear, nose, and throat diseases, Dr. Hilmi Cem Kaya provides highly effective, minimally invasive treatments. 5️⃣ Committed to Medical Excellence – Continually expanding his knowledge through research, advanced training, and hands-on experience in leading ENT departments across Turkey. Dr. Hilmi Cem Kaya is a dedicated ENT specialist, combining advanced medical knowledge, innovative techniques, and patient-centered care to deliver exceptional treatment outcomes.
  • Read more
Doctor's visit
Price on request
Info

Murat Sari

  • 5 Excellent 3 reviews
  • 9 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education and Career


    2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

    Medicine Department of Internal Medicine

    2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

    2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

    2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

    2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

    Memberships in Scientific Organizations

    ASCO

    ESMO

    TTOD 

    AVOD 

    Publications

    In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

    Awards Received

    EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

    "The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

    Speeches Delivered at National Congresses, Conferences, and Symposia:

     

    Courses, Meetings, and Certificates

    ESMO certified Medical Oncologist since 2019

  • Read more
Doctor's visit
Price on request
Info

Veysel Sari

  • 4.5 Good 3 reviews
  • 10 years of experience
  • Turkey, Istanbul, Büyük Anadolu Hospitals (BAH)
  • Specializations

     

    Oncological Surgery (Cancer Surgery)

    Breast Diseases Surgery

    Gallbladder and biliary tract diseases surgery

    Thyroid – Parathyroid Surgery

    Inguinal and Abdominal Wall Hernia, Stomach Hernia Surgery

    Closed (Laparoscopic) Hernia Surgery

    Endoscopy Applications

    Treatment of Gastrointestinal System Diseases

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

  • Read more
Doctor's visit
Price on request
Info

Hasan Mutlu

  • 3 Good 1 review
  • 26 years of experience
  • Turkey, Antalya , Medical Park Antalya Hospital Complex
  • Education and Specialization

    • Faculty of Medicine, Hacettepe University
    • 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
    • Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
    • Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
    • Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

    Work Experience

    • 2009 - Kayseri Training and Research Hospital, Hospital
    • Acıbadem Kayseri
    • 2017 - 2018 - Lara Private Anadolu Hospital
    • 2018 - Medical Park Antalya Hospital Complex

    Expertise

    • Diagnosis of organ tumors
    • Chemotherapy in cancer treatment
    • Targeted cancer therapies
    • Immunotherapy in cancer treatment
    • Next-generation genetic research in cancer treatment
    • Complementary medicine in cancer treatment
    • Medical oncology
  • Read more
Targeted therapy
$750 - $2,500
Hysterectomy (uterus removal)
$4,500 - $4,500
Prostatectomy
$8,500 - $8,500
Info

Fatma Ela Keskin

  • 5 Excellent 33 reviews
  • 16 years of experience
  • Turkey, Istanbul, Istanbul Florence Nightingale Hospital
Mastectomy
$800 - $1,000
Info

Sezer Saglam

  • 5 Excellent 33 reviews
  • 28 years of experience
  • accreditations:
  • Turkey, Istanbul, Istanbul Florence Nightingale Hospital
  • Prof. Dr. Sezer Sağlam, a leading medical oncologist at Gayrettepe Florence Nightingale Hospital, has transformed cancer care through groundbreaking research and clinical trials. His study on the optimal timing of surgery after neoadjuvant therapy for rectal cancer has influenced global treatment protocols. Specializing in gastrointestinal and breast cancers, he pioneered targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma earned a nomination for the 2024 International Best Researcher Award. A key member of ASCO, ESMO, and ENET, he delivers personalized, research-backed oncology care.
  • Read more
Mastectomy
$800 - $1,000
Info

Mehmet Fatih Kilicli

  • 5 Excellent 3 reviews
  • 33 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education and Experience

    • 1992 - 1998, Gaziantep University, Faculty of Medicine
    • 2002 – 2015, Cumhuriyet University, Faculty of Medicine, Department of Internal Medicine
    • 2015 – 2024, Bağcılar Medipol Mega University Hospital
    • 2024 – Present, Medipol Acıbadem Hospital
  • Read more
Doctor's visit
Price on request
Info

Yusuf Acikgoz

  • 4.5 Good 3 reviews
  • 9 years of experience
  • Turkey, Ankara, Lokman Hekim University Ankara Hospital
  • Associate Professor Dr. Yusuf AÇIKGÖZ
    Specialization: Medical Oncology

    Education:

    • 2004-2011: İnönü University Faculty of Medicine
    • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
    • 2017-2022: Health Sciences University, Medical Oncology

    Professional Experience:

    • 2016-2017: Bingöl City Hospital, Internal Medicine
    • 2021-2022: Health Sciences University, Medical Oncology
    • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
    • 2023-2024: Ohio State University, Medical Oncology
    • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

    Clinical Trials, Courses, Certifications:

    Clinical Trials:

    • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
    • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

    Courses:

    • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
    • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
    • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
    • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
    • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

    Certifications:

    • Ongoing: ECFMG Certification
    • 2024: CITI Responsible Conduct of Research (The Ohio State University)
    • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
    • 2024: CITI Human Subjects Protection (The Ohio State University)
    • 2024: CITI Good Clinical Practice (The Ohio State University)
    • 2023: Occupational English Test (OET)
    • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
    • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
    • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

    Memberships:

    • American Society of Clinical Oncology (ASCO) - 2022
    • Turkish Society of Medical Oncology - 2020
  • Read more
Doctor's visit
Price on request
Info

Nail Paksoy

  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Trachelectomy (cervicectomy)
$2,500 - $3,500
Resection of glioma
$12,000 - $18,000
Whipple surgery
$18,000 - $25,000
Info

Mustafa Serkan Alemdar

  • 3 Good 1 review
  • 19 years of experience
  • Turkey, Antalya , Medical Park Antalya Hospital Complex
  • Education and Specialization

    • 2006: Kocaeli University Faculty of Medicine
    • 2014: Akdeniz University Faculty of Medicine, Internal Medicine
    • 2018: Akdeniz University Faculty of Medicine, Medical Oncology

    Experience

    • 2006 - 2008: Konya Derebucak District Hospital
    • 2009 - 2015: Akdeniz University Hospital
    • 2015: Antalya Kaş State Hospital
    • 2015 - 2016: İnönü University Faculty of Medicine
    • 2016 - 2021: Akdeniz University Hospital
    • 2021 - 2023: Antalya Training and Research Hospital
  • Read more
Targeted therapy
$750 - $2,500
Hysterectomy (uterus removal)
$4,500 - $4,500
Prostatectomy
$8,500 - $8,500
Info

Ferit Çelik

  • New
  • 15 years of experience
  • Turkey, İzmir, Medicalpoint International Hospital
  • Education and Expertise

    • 2023 BAKIRÇAY UNIVERSITY ÇİĞLİ TRAINING AND RESEARCH HOSPITAL (ASSOCIATE PROFESSOR)
    • 2021 EGE UNIVERSITY FACULTY OF MEDICINE GASTROENTEROLOGY DEPARTMENT
    • 2017 EGE UNIVERSITY INTERNAL MEDICINE DEPARTMENT
    • 2010 EGE UNIVERSITY FACULTY OF MEDICINE

    Diseases

    • Liver Diseases
    • Digestive System Diseases

    Treatment Methods

    • Endoscopy
    • Endoscopic mucosal resection – EMR
    • Endoscopic Obesity Treatment (Intragastric Botox, Intragastric Balloon)
    • Endoscopic Polypectomy
    • Endoscopic Retrograde Cholangio Pancreatography (ERCP)
    • Liver Transplant
    • Colonoscopy
    • Peroral Cholangioscopy

    Experience

    • Diyarbakir 112 Emergency Health Services Chief Physician (2010-2011)
    • Ege University Faculty of Medicine, Department of Internal Medicine (2012-2017)
    • Ayvalik State Hospital (2017-2018)
    • Ege University Faculty of Medicine, Department of Gastroenterology (2018-2021)
    • Burdur State Hospital (2021-2022)
    • Bakırçay University Çiğli Training and Research Hospital (2022-2024)

    Professional Memberships

    • 1.Turkish Gastroenterology Association (ERCP working group)
    • 2. Turkish Liver Research Association
    • 3. Turkish Medical Association
  • Read more
Doctor's visit
Price on request
Info

Ayse Kubat Uzum

  • New
  • 27 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Education

    • Undergraduate: Çukurova University, Faculty of Medicine 1992-1998
    • Specialty Education: Istanbul Training and Research Hospital 1998-2003
    • Subspecialization: IU Istanbul Faculty of Medicine 2004-2007
    •  

    Experience

    • Istanbul Training and Research Hospital 1998-2003
    • IU Istanbul Faculty of Medicine 2004-2007
    • Istanbul Training and Research Hospital 2007-2009
    • Şanlıurfa Training and Research Hospital 2009-2011
    • Bağcılar Training and Research Hospital August 2011- November 2011
    • Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases December 2011- 2014
    • Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2014-2020
    • Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2020-2024

     

    Scientific Memberships
     

    • Turkish Society of Endocrinology and Metabolic Diseases (Vice President)
    • European Society of Endocrinology;
    • Endosociety

     

    Awards

     

    1. 1. Bestclinical scientific publication support award (53rd National Diabetes Congress, 2017)
    2. 2. 54th National Diabetes Congress (2018) with the study titled "The effects of adding pre-probiotics to the diets of patients with gastric bypass (GBP) on metabolic parameters, icretin levels and hunger, satiety and appetite scores of patients".

    Medical Intrests

    • Diabetes
    • Thyroid diseases (hypothyroidism, hyperthyroidism, thyroid nodules)
    • Pituitary diseases
    • Adrenal gland diseases
    • Osteoporosis
  • Read more
Complex treatment of thyroid cancer
$200 - $200
Info

Esra Demir

  • 5 Excellent 3 reviews
  • 16 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education:

    • Degree: Faculty of Medicine, Trakya University, 2009
    • Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
    • Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
    • Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
    • Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
    • Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

    Roles in Projects:

    Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

    Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

    Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

    Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

    Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

  • Read more
Doctor's visit
Price on request
Info

Choosing Right Doctor and Clinic: Insider Tips

When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team